TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/30/2025
Back to search
Official data from USPTO
OCTAPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
02/04/2025
Trademark type
Word
Nice classes
5
Filing date
09/20/2001
Registration date
04/05/2005
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/27/2024
Last transaction
02/04/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/30/2004
First use in commerce
06/30/2004
Drawing code
1
Owner type
03
Owner location
Lachen, CH
Examiner
CASE, LEIGH CAROLINE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Octapharma AG
Representatives
Henry B. Ward, III Bradley Arant Boult Cummings LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsnamely blood plasma derivatives in the nature of virus inactivated blood plasmablood clotting factorsimmunoglobulins
Publications
History of USPTO decisions and trademark events.
48 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/30/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
01/30/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/30/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/30/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/30/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/30/2025
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/27/2024
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
12/27/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/27/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/27/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
09/13/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
04/05/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/09/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/09/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/09/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/09/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
03/26/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/12/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/12/2011
E815
TEAS SECTION 8 & 15 RECEIVED
04/04/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
04/05/2005
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
01/03/2005
ALIE
ASSIGNED TO LIE
12/30/2004
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/22/2004
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/22/2004
EX4G
SOU EXTENSION 4 GRANTED
12/22/2004
IUAF
USE AMENDMENT FILED
12/03/2004
EXT4
SOU EXTENSION 4 FILED
12/03/2004
PAPER RECEIVED
12/03/2004
EX3G
SOU EXTENSION 3 GRANTED
06/25/2004
CFIT
CASE FILE IN TICRS
06/15/2004
EXT3
SOU EXTENSION 3 FILED
06/03/2004
PAPER RECEIVED
06/03/2004
DOCK
ASSIGNED TO EXAMINER
04/26/2004
EX2G
SOU EXTENSION 2 GRANTED
01/07/2004
EXT2
SOU EXTENSION 2 FILED
12/03/2003
PAPER RECEIVED
12/03/2003
EX1G
SOU EXTENSION 1 GRANTED
06/26/2003
EXT1
SOU EXTENSION 1 FILED
05/29/2003
PAPER RECEIVED
05/29/2003
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/03/2002
PUBO
PUBLISHED FOR OPPOSITION
09/10/2002
NPUB
NOTICE OF PUBLICATION
08/21/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/29/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/18/2002
CNRT
NON-FINAL ACTION MAILED
11/27/2001
DOCK
ASSIGNED TO EXAMINER
11/20/2001
Continuous trademark protection
Get notified about every new filing that threatens OCTAPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.